Chlorophenyl-quinolin-1,3,4-oxadiazol-thio-acetamide
AChE IC50 0.033 microM
General
Type : Sulfur Compound, Quinoline, Oxadiazol, Carboxamide
Chemical_Nomenclature : N-(4-Chlorophenyl)-2-[[5-((quinolin-8-yloxy)methyl)-1,3,4-oxadiazol-2-yl]thio]acetamide
Canonical SMILES : C1(=NN=C(O1)COC2=C3C(=CC=C2)C=CC=N3)SCC(NC4=CC=C(C=C4)Cl)=O
InChI : InChI=1S\/C20H15ClN4O3S\/c21-14-6-8-15(9-7-14)23-17(26)12-29-20-25-24-18(28-20)11-27-16-5-1-3-13-4-2-10-22-19(13)16\/h1-10H,11-12H2,(H,23,26)
InChIKey : FUDDPXUJNXGLNI-UHFFFAOYSA-N
Other name(s) : Compound 5a
Target
Families : Chlorophenyl-quinolin-1,3,4-oxadiazol-thio-acetamide ligand of proteins in family
ACHE
References (1)
| Title : Exploring Novel Quinoline-1,3,4-Oxadiazole Derivatives for Alzheimer's Disease: Their Design, Synthesis, and In-Vitro and In-Silico Investigations - Saffour_2024_Curr.Med.Chem__ |
| Author(s) : Saffour S , Evrim Evren A , Saglik BN , Yurttas L |
| Ref : Curr Med Chem , : , 2024 |
| Abstract : |
| PubMedSearch : Saffour_2024_Curr.Med.Chem__ |
| PubMedID: 39206477 |